Literature DB >> 24101303

Can posterior dynamic stabilization reduce the risk of adjacent segment deterioration?

Zhi-Jie Zhou1, Ping Xia, Xing Zhao, Xiang-Qian Fang, Feng-Dong Zhao, Shun-Wu Fan.   

Abstract

AIM: The aim of this study was to systematically review the relevant literature to develop a benchmark for the incidence of adjacent segment degeneration (ASDeg) and adjacent segment disease (ASDis) following the posterior dynamic stabilization (PDS) procedure and to investigate whether conclusions can be made with regard to the isolated PDS procedure in reducing the risk of ASDeg and ASDis compared with fusion, and with regard to the role of additional PDS devices implanted adjacent to fusion in protecting from ASDeg and ASDis caused by the neighboring fusion.
MATERIAL AND METHODS: We retrieved electronic databases of Medline, Ovid and Cochrane Central Registry of Controlled Trials, combined with a supplemental hand search. Thirty-one articles met our inclusion criteria.
RESULTS: The pooled incidence of ASDeg and ASDis following PDS procedure was 16.4% and 5.5% respectively. Data from comparative studies showed a significantly lower incidence of ASDeg and nonsignificantly lower incidence of ASDis following PDS than following fusion surgery. Further, the additional PDS devices implanted adjacent to fusion could significantly reduce the risk of ASDeg and nonsignificantly decrease that of ASDis caused by fusion.
CONCLUSION: These results suggested relative success of the PDS procedure in protecting against ASDeg and ASDis.

Entities:  

Mesh:

Year:  2013        PMID: 24101303     DOI: 10.5137/1019-5149.JTN.6573-12.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  8 in total

1.  Interspinous dynamic stabilization adjacent to fusion versus double-segment fusion for treatment of lumbar degenerative disease with a minimum follow-up of three years.

Authors:  Xiao-Long Chen; Li Guan; Yu-Zeng Liu; Jin-Cai Yang; Wen-Long Wang; Yong Hai
Journal:  Int Orthop       Date:  2016-04-27       Impact factor: 3.075

2.  Short term outcome of posterior dynamic stabilization system in degenerative lumbar diseases.

Authors:  Mingyuan Yang; Chao Li; Ziqiang Chen; Yushu Bai; Ming Li
Journal:  Indian J Orthop       Date:  2014-11       Impact factor: 1.251

3.  Evaluation of a Hybrid Dynamic Stabilization and Fusion System in the Lumbar Spine: A 10 Year Experience.

Authors:  Ahmed Kashkoush; Nitin Agarwal; Erin Paschel; Ezequiel Goldschmidt; Peter C Gerszten
Journal:  Cureus       Date:  2016-06-10

4.  Minimally invasive procedure reduces adjacent segment degeneration and disease: New benefit-based global meta-analysis.

Authors:  Xiao-Chuan Li; Chun-Ming Huang; Cheng-Fan Zhong; Rong-Wei Liang; Shao-Jian Luo
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

Review 5.  Dynamic Stabilization Adjacent to Fusion versus Posterior Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Disease: A Meta-Analysis.

Authors:  Xiangyao Sun; Zhaoxiong Chen; Siyuan Sun; Wei Wang; Tongtong Zhang; Chao Kong; Shibao Lu
Journal:  Biomed Res Int       Date:  2020-05-20       Impact factor: 3.411

6.  Dynamic stabilization for degenerative diseases in the lumbar spine: 2 years results.

Authors:  Ahmed Hosny Khalifa; Timo Stübig; Oliver Meier; Christian Walter Müller
Journal:  Orthop Rev (Pavia)       Date:  2018-04-04

7.  Long-Term Outcome of Dynesys Dynamic Stabilization for Lumbar Spinal Stenosis.

Authors:  Yang Zhang; Zhi-Cheng Zhang; Fang Li; Tian-Sheng Sun; Jian-Lin Shan; Kai Guan; Guang-Min Zhao; Li-Zhi Zhang
Journal:  Chin Med J (Engl)       Date:  2018-11-05       Impact factor: 2.628

8.  Adjacent segment disease following Dynesys stabilization for lumbar disorders: A case series of mid- and long-term follow-ups.

Authors:  Kuan-Ju Chen; Chien-Ying Lai; Lu-Ting Chiu; Wei-Sheng Huang; Pang-Hsuan Hsiao; Chien-Chun Chang; Cheng-Jyh Lin; Yuan-Shun Lo; Yen-Jen Chen; Hsien-Te Chen
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.